Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 16, 1999

View Archived Issues

Maxamine advances in phase II and III trials during Q2 1999

Aastrom Biosciences enters distribution agreements for Norway and Switzerland

Cell Therapeutics advances oncology portfolio in Q2 1999

CpG ImmunoPharmaceuticals obtains financing for additional clinical trials

Immune Complex Corporation awarded SBIR contract to detect cytochrome P450 polymorphisms

NIH initiates interstitial cystitis trial

Iomed begins phase III trials of IontoDex for inflammation

ACES will evaluate azithromycin in heart disease

GlycoDesign to acquire Vascular Therapeutics

NexMed reports results from multiple-use study of topical alprostadil cream

ImClone Systems initiates phase II C225/cisplatin trial

Nexell launches first product from Cytonex diagnostic line

AdProTech reaches C3d adjuvant licensing agreement with University of Cambridge

Tyrosine kinase inhibitors potentially useful for patient-specific treatment of tumors

Triazepinone compounds from Merck KGaA act as AGE formation inhibitors

Creative BioMolecules, NeoGenesis team up to identify new drugs to treat degenerative disorders

Leading BPH treatment to be copromoted by Abbott and Boehringer Ingelheim

5-HT1A receptor agonist LB-50016, a novel putative anxiolytic and antidepressant

Antiangiogenic drug ZD-4190 excels in preclinical testing at AstraZeneca

Merck's newest alphavbeta3 ligands prevent osteoclast-mediated bone resorption

Centaur researches novel treatments for Alzheimer's disease

Preclinical study results indicate efficacy of thiazolidinediones in IBD

Improved NNRTIs reported by Medivir in patent literature

Cangene receives notification of fast-track status for new anti-chickenpox product

IL-8 antagonists with broad therapeutic potential synthesized at SmithKline Beecham

Sanofi-Synthelabo submits MAA for Ditropan XL in the U.K.

Alusuisse-Lonza announces demerger plans

Argent gene delivery platform used successfully for sustained, controlled delivery of hGH

Remune clinical trial commences in South America

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 17, 2025.
Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA
BioWorld
During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...
23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...